ω-3 Fatty acids (fish oil) as an anti-inflammatory: An alternative to nonsteroidal anti-inflammatory drugs for discogenic pain

Surgical Neurology

Volumn 65, Issue 4, 2006, Pages 326-331

  Maroon, Joseph Charles ^a   Bost, Jeffrey W ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

3 EFA; Nonsteroidal anti inflammatory drugs; Spine pain

Indexed keywords

DECOSAHEXAENOIC ACID; FISH OIL; HEXANOIC ACID DERIVATIVE; ICOSAPENTAENOIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; UNCLASSIFIED DRUG;

ANALGESIA; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACKACHE; CONTROLLED STUDY; DIET SUPPLEMENTATION; HUMAN; INTERVERTEBRAL DISK; MAJOR CLINICAL STUDY; NECK PAIN; NEUROSURGERY; PAIN ASSESSMENT; PATIENT SATISFACTION; QUESTIONNAIRE; SPINAL PAIN; TREATMENT OUTCOME;

ALPROSTADIL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRALGIA; BACK PAIN; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; FATTY ACIDS, OMEGA-3; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERVERTEBRAL DISK DISPLACEMENT; NECK PAIN; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 33644923483     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surneu.2005.10.023     Document Type: Article

References (39)

1. H.P. Ammon, H. Safayhi, T. Mack, and J. Sabieraj Mechanism of anti-inflammatory actions of curcumine and boswellic acids J Ethnopharmacol 38 2-3 1993 113 119
2. H.D. Adkisson, T.M. Tranik, and R.E. Wuthier Relationship of cartilage Mead acid levels to aging and development of osteoarthritis Third International Conference on Essential Fatty Acids and Eicosanoids, Adelaide, Australia March 1 1992
3. J.J. Belch Effects of altering the dietary essential fatty acids on the requirements for NSAIDs in patients with rheumatoid arthritis Ann Rheum Dis 47 1988 96 104
4. R.S. Bresalier Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial N Engl J Med 2004 352
5. Y. Cadroy, D. DuPout, and B. Doneau Arachidonic acid enhances the tissue expression of mononuclear cells by the cyclooxygenase 1 pathway; beneficial effects of n-3 fatty acids J Immunol 1998 6145 6150
6. L.G. Cleland Clinical and biochemical effects of dietary fish oil supplements in rheumatoid arthritis J Rheumatol 15 1988 1471 1475
7. U.N. Das Interaction(s) between essential fatty acids, eicosanoids, cytokines, growth factors and free radicals-relevance to new therapeutic strategies in rheumatoid arthritis and other collagen vascular diseases Prostaglandins Leukot Essent Fatty Acids 44 4 1991 201 210
8. J.M. Drazen Cox-2 inhibitors-a lesson in unexpected problems [Editorial] N Engl J Med 2004 352
9. J.F. Graumlich Preventing gastrointestinal complications of NSAIDs: risk factors, recent advances, and latest stratagies Postgrad Med 109 5 2001 117 128
10. L.P. Hale, P.K. Greer, and G.D. Sempowski Bromelain treatment alters leukocyte expression of cell surface molecules involved in cellular adhesion and activation Clin Immunol 104 2 2002 183 190
11. J.D. Kang, H.I. Georgescu, L. McIntyre-Larkin, M. Stefanovic-Racic, and C.H. Evans Herniated cervical intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6 and prostaglandin E2 Spine 20 1995 2373 2378
12. J.D. Kang, M. Stefanovic-Racic, L.A. McIntyre, H.I. Georgescu, and D.H. Evans Toward a bio-chemical understanding of human intervertebral disc degeneration and herniation: contributions of nitric oxide, interleukins, prostaglandin E2, and matrix metalloproteinases Spine 22 1997 1065 1073
13. J.M. Kremer, D.A. Lawrence, D.R. Robinson, and J. Bigaouette Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal anti-inflammatory drugs: clinical and immune correlates Arthritis Rheum 38 8 1995 1107 1114
14. J.M. Kremer Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis Arthritis Rheum 33 6 1990 810 820
15. J.M. Kremer Fish oil fatty acid supplementation in active rheumatoid arthritis Ann Intern Med 50 3 1987 78 85
16. J.M. Kremer n-3 fatty acid supplements in rheumatoid Am J Clin Nutr 71 2000 349S 351S
17. Tar L, Tar K. Stop prescribing Cox-2 inhibitors? A medico-legal analysis, Allegheny County Medical Society Bulletin, June 2005. p. 293-6.
18. H.R. Maurer Bromelain: biochemistry, pharmacology and medical use Cell Mol Life Sci 58 9 2001 1234 1245
19. R.F. McCarron, M.W. Wimpee, P.G. Hudkins, and G.S. Laros The inflammatory effect of nucleus pulposus: a possible element in the pathogenesis of low-back pain Spine 12 1987 760 764
20. H. Miyamoto, R. Saura, M. Doita, M. Kurosaka, and K. Mizuno The role of cyclooxygenase-2 in lumbar disc herniation Spine 27 22 2002 2477 2483
21. R.W. Morgan Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs N Engl J Med 341 18 1999 1397 1399
22. J.L. O'Donnell, and A.L. O'Donnell Prostaglandin E2 content in herniated lumbar disc disease Spine 21 1996 1653 1656
23. J.H. O'Keefe, and W.S. Harris From intuit to implementation: omega-3 fatty acids come of age Mayo Clin Proc 75 6 2000 607 614
24. B.M. Psaty Cox-2 inhibitors-lessons in drug safety [Editorial] N Engl J Med 2005 352
25. S. Roth Nonsteroidal anti-inflammatory drug gastropathy: we started it, why don't we stop it? J Rheumatol 32 2005 1189 1191
26. J.S. Saal, R.C. Franson, R. Dobrow, J.A. Sall, A.H. White, and N. Goldthwaite High levels of inflammatory phospholipase A2 activity in lumbar disc herniations Spine 14 1990 674 678
27. S. Sethi Inhibition of leukocyte-endothelial interactions by oxidized omega-3 fatty acids: a novel mechanism for the anti-inflammatory effects of omega-3 fatty acids in fish oil Redox Rep 7 6 2002 369 378
28. A.P. Simopoulos Omega-3 fatty acids in inflammation and autoimmune diseases J Am Coll Nutr 21 6 2002 495 505
29. G. Singh Gastrointestinal complications of prescription and over-the-counter nonsteroidal anti-inflammatory drugs: a view from the ARAMIS database. Arthritis, Rheumatism, and Aging Medical Information System Am J Ther 7 2 2000 115 121
30. S.D. Solomon Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention N Engl J Med 2005 352
31. T. Stammers, B. Sibbald, and P. Freeling Fish oil in osteoarthritis Lancet 2 1989 503
32. T. Stammers, B. Sibbald, and P. Freeling Efficacy of cod liver oil as an adjunct to non-steroidal anti-inflammatory drug treatment in the management of osteoarthritis in general practice Ann Rheum Dis 51 1992 128 129
33. H. Takahashi, T. Suguro, Y. Okazima, M. Motegi, Y. Okada, and T. Kakiuchi Inflammatory cytokines in the herniated disc of the lumbar spine Spine 21 2 1996 218 224
34. J. Vane, and R. Botting Inflammation and the mechanism of action of anti-inflammatory drugs FASEB J 1 1981 89 96
35. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971;231:232-5.
36. Vane JR. Nat New Biol. Volumes 480-481, 1 September 2001, p. 243-8.
37. C. Wang, M. Chung, and A. Lichtenstein Effects of omega-3 fatty acids on cardiovascular disease. Evidence report/technology assessment number 94. AHRQ publication number 04-E009-1 2004 Agency for Healthcare Research Rockville, (MD)
38. W.S. Harris, and C. von Schacky The omega-3 index: a new risk factor for death from coronary heart disease? Prev Med 39 2004 212 220
39. Young-Joon Surh, Chun KS, Cha HH, Han SS, et al. Molecular mechanisms underlying chemo-preventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation. Mutat Res 2001;480-1:243-68.